Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 5
2015 1
2016 4
2018 4
2019 2
2020 4
2021 2
2022 6
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.
Cinti S, Tomassi S, Ciardiello C, Migliorino R, Pirozzi M, Leone A, Di Gennaro E, Campani V, De Rosa G, D'Amore VM, Di Maro S, Donati G, Singh S, Raucci A, Di Leva FS, Kessler H, Budillon A, Marinelli L. Cinti S, et al. Among authors: campani v. Commun Chem. 2024 Mar 21;7(1):60. doi: 10.1038/s42004-024-01144-z. Commun Chem. 2024. PMID: 38514757 Free PMC article.
Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage.
Cepparulo P, Cuomo O, Campani V, Vinciguerra A, Sisalli MJ, Nele V, Anzilotti S, Valsecchi V, Casamassa A, Brancaccio P, Scorziello A, De Rosa G, Annunziato L, Pignataro G. Cepparulo P, et al. Among authors: campani v. Mol Ther Nucleic Acids. 2024 Feb 2;35(1):102131. doi: 10.1016/j.omtn.2024.102131. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38379726 Free PMC article.
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer.
Abate M, Lombardi A, Luce A, Porru M, Leonetti C, Bocchetti M, Campani V, De Rosa G, Graziano SF, Nele V, Cardile F, Marino FZ, Franco R, Ronchi A, Scrima M, Sperlongano R, Alfano R, Misso G, Amler E, Caraglia M, Zappavigna S. Abate M, et al. Among authors: campani v. Mol Ther Nucleic Acids. 2023 Jun 19;33:127-141. doi: 10.1016/j.omtn.2023.06.012. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37449042 Free PMC article.
The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
Rigillo G, Belluti S, Campani V, Ragazzini G, Ronzio M, Miserocchi G, Bighi B, Cuoghi L, Mularoni V, Zappavigna V, Dolfini D, Mercatali L, Alessandrini A, Imbriano C. Rigillo G, et al. Among authors: campani v. Cancer Lett. 2023 Jul 28;567:216262. doi: 10.1016/j.canlet.2023.216262. Epub 2023 Jun 10. Cancer Lett. 2023. PMID: 37307894 Free article.
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Dinami R, Pompili L, Petti E, Porru M, D'Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, Serra V, Mano M, Giacca M, Leonetti C, Ciliberto G, Tarsounas M, Stoppacciaro A, Schoeftner S, Biroccio A. Dinami R, et al. Among authors: campani v. EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25. EMBO Mol Med. 2023. PMID: 36426578 Free PMC article.
36 results